Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Staphylococcus aureus cell wall-anchored (CWA) proteins are a diverse group of surface-exposed proteins covalently linked to the peptidoglycan layer, primarily by the transpeptidase enzyme sortase A (Foster et al., 2014, Nature Reviews Microbiology). These proteins, often categorized as Microbial Surface Components Recognizing Adhesive Matrix Molecules (MSCRAMMs), play pivotal roles in the pathogenesis of S. aureus by mediating attachment to host extracellular matrix components like fibrinogen, fibronectin, and collagen (Speziale et al., 2009, Frontiers in Bioscience). Beyond adhesion, CWA proteins such as Protein A (Spa) facilitate immune evasion by binding the Fc region of IgG, thereby inhibiting opsonization and phagocytosis (Mazmanian et al., 1999, Science). They are also critical for biofilm formation and nutrient acquisition, such as the Isd proteins involved in heme-iron scavenging from host hemoglobin. Given their essential roles in colonization and virulence, CWA proteins are major targets for the development of vaccines and monoclonal antibodies aimed at preventing or treating invasive staphylococcal infections (Missiakas & Schneewind, 2016, Cold Spring Harbor Perspectives in Medicine). However, the functional redundancy and high genetic variability among different S. aureus strains present significant challenges for therapeutic targeting, often requiring multi-antigen approaches (ClinicalTrials.gov, 2023).
Inhibition of bacterial attachment to host tissues and neutralization of immune-evasive surface factors to facilitate opsonophagocytic clearance by host immune cells.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Staphylococcus aureus cell wall-anchored proteins and peptidoglycan-associated surface proteins (CWA proteins).